Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Barnwik AB was a Swedish venture capital and investment firm that focused on early-stage opportunities within the life sciences and biotechnology sectors. The company is best known for its strategic investments in prominent biotech entities such as Cellartis AB, a leader in pluripotent stem cell technology, and Domantis Ltd, a pioneer in domain antibody therapeutics. Based in Kullavik, Sweden, Barnwik played a role in the Nordic biotech ecosystem during the 2000s by providing essential financing for drug discovery and regenerative medicine platforms. The company is no longer active, with its investment operations concluding following the acquisition of its major portfolio companies by larger pharmaceutical and biotech firms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Barnwik.